Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a dismal prognosis. Despite efforts to improve therapy outcomes in PDAC, overall survival remains at 2 to 5 years following initial diagnosis. To date, there are no established predictive or prognostic biomarkers for PDAC tumors. The availability of digitized H&E stained whole slide images (WSI) has led to an uptake in deep learning-based approaches toward comprehensive, automatic interrogation of tumor-specific attributes for disease diagnosis and prognosis. However, a significant challenge with the interrogation of large WSIs (gigabytes in size) is that only a small portion of the tissue (i.e. ROIs) contains information pertinent to diagnosis or prognosis. In this work, we investigated whether “highattention” ROIs (i.e. patch regions) identified by an attention-driven model to differentiate tumor from benign regions, may also be associated with survival outcomes in PDAC patients. The attention model was developed using a total of n = 461 WSI of H&E-stained pancreatic tumors, from two public repositories. Our approach first identifies attention maps (i.e. ROIs) using clustering-constrained-attention multiple-instance learning (CLAM), on WSI labeled as PDAC versus benign pancreas. Subsequently, the learned attention maps are employed within a LASSO regularized Cox-hazard proportional model to distinguish between high and low survival-risk groups of PDAC patients. Results were evaluated via a log-rank test and compared with established demographic variables (age, sex, race) to predict survival risk. While individual demographic variables did not demonstrate significant differences in survival risk, the attention-driven WSI features yielded significant stratification of low and highrisk groups in both the training (p = 0.0014, Hazard Ratio (HR), 2.0 (95 % Confidence Interval (CI) 1.3 -3.1)) and the test set (p = 0.0012 HR = 2.0 (95 % CI 1.3 -2.6)). Following a large, multi-institutional validation, our deep-learning approach may allow for designing more precise prognostic and predictive histopathological biomarkers for PDAC tumors.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.